CNBX Pharmaceuticals, Inc. (CNBX)
0.0001
0.00 (0.00%)
USD |
OTCM |
Sep 23, 16:00
CNBX Pharmaceuticals Cash from Operations (TTM) : -0.1542M for May 31, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| May 31, 2026 | -0.1542M |
| February 28, 2026 | -0.1585M |
| November 30, 2025 | -0.1796M |
| August 31, 2025 | -0.1713M |
| May 31, 2025 | -0.191M |
| February 28, 2025 | -0.1388M |
| November 30, 2024 | -0.2115M |
| August 31, 2024 | -0.2443M |
| May 31, 2024 | -0.1755M |
| February 29, 2024 | -0.1943M |
| November 30, 2023 | -0.0885M |
| August 31, 2023 | -0.1125M |
| May 31, 2023 | -0.2825M |
| February 28, 2023 | -0.6393M |
| November 30, 2022 | -1.176M |
| August 31, 2022 | -1.679M |
| May 31, 2022 | -2.112M |
| February 28, 2022 | -2.352M |
| November 30, 2021 | -2.500M |
| August 31, 2021 | -2.493M |
| May 31, 2021 | -2.625M |
| February 28, 2021 | -2.585M |
| November 30, 2020 | -2.606M |
| August 31, 2020 | -2.775M |
| May 31, 2020 | -2.930M |
| Date | Value |
|---|---|
| February 29, 2020 | -3.173M |
| November 30, 2019 | -3.188M |
| August 31, 2019 | -3.094M |
| May 31, 2019 | -2.847M |
| February 28, 2019 | -2.494M |
| November 30, 2018 | -2.189M |
| August 31, 2018 | -1.975M |
| May 31, 2018 | -1.697M |
| February 28, 2018 | -1.436M |
| November 30, 2017 | -1.170M |
| August 31, 2017 | -0.8636M |
| May 31, 2017 | -0.5895M |
| February 28, 2017 | -0.3729M |
| November 30, 2016 | -0.2314M |
| August 31, 2016 | -0.1201M |
| May 31, 2016 | -0.0787M |
| February 29, 2016 | -0.0742M |
| November 30, 2015 | -0.1051M |
| August 31, 2015 | -0.1791M |
| May 31, 2015 | |
| February 28, 2015 | |
| November 30, 2014 | |
| August 31, 2014 | |
| May 31, 2014 | -0.1355M |
| February 28, 2014 | -0.1091M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Cocrystal Pharma, Inc. | -8.263M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | -207.00M |
| Fulcrum Therapeutics, Inc. | -65.78M |
| Definium Therapeutics, Inc. | -166.74M |